My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 91

    1.

    Anti-VEG F agents for diabetic maculopathy.

    Salam A, Dacosta J, Sivaprasad S.

    Br J Ophthalmol. 2009 Jun 24. [Epub ahead of print]PMID: 19556214 [PubMed - as supplied by publisher]Related articles

    2.

    Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy.

    Simó R, Hernández C.

    Diabetologia. 2008 Sep;51(9):1574-80. Epub 2008 Apr 11. Review.PMID: 18404258 [PubMed - indexed for MEDLINE]Related articles

    3.

    Novel drug delivery systems for retinal diseases. A review.

    Lee SS, Robinson MR.

    Ophthalmic Res. 2009;41(3):124-35. Epub 2009 Mar 26. Review.PMID: 19321933 [PubMed - indexed for MEDLINE]Related articles

    4.

    An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema.

    Do DV, Nguyen QD, Shah SM, Browning DJ, Haller JA, Chu K, Yang K, Cedarbaum JM, Vitti RL, Ingerman A, Campochiaro PA.

    Br J Ophthalmol. 2009 Feb;93(2):144-9.PMID: 19174400 [PubMed - indexed for MEDLINE]Related articles

    5.

    Update on the treatment of diabetic retinopathy.

    Yam JC, Kwok AK.

    Hong Kong Med J. 2007 Feb;13(1):46-60. Review.PMID: 17277392 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results.

    Eyetech Study Group.

    Ophthalmology. 2003 May;110(5):979-86.PMID: 12750101 [PubMed - indexed for MEDLINE]Related articles

    7.

    Corticosteroids in posterior segment disease: an update on new delivery systems and new indications.

    Ciulla TA, Walker JD, Fong DS, Criswell MH.

    Curr Opin Ophthalmol. 2004 Jun;15(3):211-20. Review.PMID: 15118508 [PubMed - indexed for MEDLINE]Related articles

    8.

    Vascular endothelial growth factor gene regulation and action in diabetic retinopathy.

    Lu M, Adamis AP.

    Ophthalmol Clin North Am. 2002 Mar;15(1):69-79. Review.PMID: 12064083 [PubMed - indexed for MEDLINE]Related articles

    9.

    Interventions for diabetic macular oedema: a systematic review of the literature.

    O'Doherty M, Dooley I, Hickey-Dwyer M.

    Br J Ophthalmol. 2008 Dec;92(12):1581-90. Epub 2008 Oct 24. Review.PMID: 18952646 [PubMed - indexed for MEDLINE]Related articles

    10.

    Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.

    Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Liou GI, Caldwell RW.

    Curr Drug Targets. 2005 Jun;6(4):511-24. Review.PMID: 16026270 [PubMed - indexed for MEDLINE]Related articles

    11.

    Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.

    Emerson MV, Lauer AK.

    BioDrugs. 2007;21(4):245-57. Review.PMID: 17628122 [PubMed - indexed for MEDLINE]Related articles

    12.

    VEGF antagonists.

    Hasan J, Jayson GC.

    Expert Opin Biol Ther. 2001 Jul;1(4):703-18. Review.PMID: 11727506 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Development of antituberculous drugs: current status and future prospects]

    Tomioka H, Namba K.

    Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese. PMID: 17240921 [PubMed - indexed for MEDLINE]Related articles

    14.

    Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.

    Lunsford LD, Flickinger JC, Larson D.

    Oncologist. 1997;2(1):59-61.PMID: 10388030 [PubMed - as supplied by publisher]Related articlesFree article

    15.

    Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.

    Fang X, Sakaguchi H, Gomi F, Oshima Y, Sawa M, Tsujikawa M, Ikuno Y, Kamei M, Kusaka S, Tano Y.

    Acta Ophthalmol. 2008 Nov;86(7):800-5. Epub 2008 Jun 11.PMID: 18547274 [PubMed - indexed for MEDLINE]Related articles

    16.

    Anticancer Drug Development: The Way Forward.

    Connors T.

    Oncologist. 1996;1(3):180-181.PMID: 10387985 [PubMed - as supplied by publisher]Related articlesFree article

    17.

    Integration of novel agents in the treatment of colorectal cancer.

    Iqbal S, Lenz HJ.

    Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S32-9. Review.PMID: 15309512 [PubMed - indexed for MEDLINE]Related articles

    18.

    The Challenge of Developing New Therapies for Childhood Cancers.

    Balis FM.

    Oncologist. 1997;2(1):I-II.PMID: 10388032 [PubMed - as supplied by publisher]Related articlesFree article

    19.

    Macular function after intravitreal triamcinolone acetonide injection for diabetic macular oedema.

    Karacorlu M, Ozdemir H, Senturk F, Karacorlu SA, Uysal O.

    Acta Ophthalmol. 2009 Apr 27. [Epub ahead of print]PMID: 19432873 [PubMed - as supplied by publisher]Related articles

    20.

    Eye disorders in diabetes: potential drug targets.

    Josifova T, Schneider U, Henrich PB, Schrader W.

    Infect Disord Drug Targets. 2008 Jun;8(2):70-5. Review.PMID: 18537702 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity